Form 4: Catalyst Pharma Chairman McEnany Reports Stock Transactions
Insider Transaction Report
Patrick J. McEnany, Chairman of Catalyst Pharmaceuticals, reported the vesting of restricted stock units and subsequent tax-related share disposition.
Summary
- Patrick J. McEnany, a Director and Chairman of the Board of Directors of Catalyst Pharmaceuticals, Inc. (CPRX), reported transactions on December 29, 2025.
- He acquired 26,334 shares of common stock through the vesting of restricted stock units (RSUs).
- Concurrently, 6,786 shares were disposed of to satisfy applicable withholding taxes upon the vesting of restricted stock.
- Following these transactions, McEnany beneficially owns 4,171,559 shares of common stock directly.
- He also holds 1,851,948 derivative securities in the form of Restricted Stock Units.
- The restricted stock units vested in equal tranches, with 1/3rd vesting on December 27, 2023, 1/3rd on December 27, 2024, and the final 1/3rd on December 27, 2025.
- The final tranche of shares was delivered to the reporting person on December 29, 2025.
Sentiment
Score: 5
Explanation: Neutral. This is a routine insider transaction (vesting and tax withholding) and does not indicate a significant positive or negative sentiment about the company's future performance or stock price from the insider's perspective beyond the pre-scheduled RSU plan.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor dilution from RSU vesting, but offset by tax withholding. Overall, a routine compensation event for a key executive.
Key Dates
| Date | Description |
|---|---|
| 12/27/2023 | First tranche of restricted stock units vested. |
| 12/27/2024 | Second tranche of restricted stock units vested. |
| 12/27/2025 | Third and final tranche of restricted stock units vested. |
| 12/29/2025 | Date of earliest transaction, shares delivered to reporting person, and tax withholding occurred. |
| 12/30/2025 | Date the Form 4 was signed. |
Keywords
Catalyst Pharmaceuticals, CPRX, Patrick J. McEnany, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Common Stock, Director, Chairman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.